Jadhavara PS, Ramachandrana SA, Riquelme E, Guptaa A, Quinnc KP, Shivakumard D, Rayd S, Zendea D, Nayaka AK, Miglania SK, Sathea BD, Rajaa M, Farias O, Alfaro IE, Belmar S, Guerrero J, Bernales S, Chakravartyc S, Hung DT, Lindquist JN, Raic R (2016). Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors. Bioorg Med Chem Lett. 26(21):5222-5228.

Jadhavara PS, Ramachandrana SA, Riquelme E, Guptaa A, Quinnc KP, Shivakumard D, Rayd S, Zendea D, Nayaka AK, Miglania SK, Sathea BD, Rajaa M, Farias O, Alfaro IE, Belmar S, Guerrero J, Bernales S, Chakravartyc S, Hung DT, Lindquist JN, Raic R (2016). Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors. Bioorg Med Chem Lett. 26(21):5222-5228.

[↓]